Lanadelumab

ATC B06AC05 · 10 markets · 27 records

Lanadelumab 10 markets · 27 records Forms

Filters

MarketAU 5 GB 4 CA 4 US 3 FR 3 SG 2 ES 2 TW 1 HK 1 EU 1

Strength

AU 5 records · 3 shown of 3 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

300 mg/2 mLinjectionTAKHZYRO also in GB·FR·SG
300 mginjectionTAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe+1TAKHZYRO lanadelumab 300mg/2mL solution for injection vial also in ES unknown
150 mginjectionTAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe also in ES unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Takhzyro PFS ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

GB 4 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

300 mg/2 mLinjectionTakhzyro 300mg/2ml solution for injection pre-filled pens+2Takhzyro 300mg/2ml solution for injection pre-filled syringes、Takhzyro 300mg/2ml solution for injection vials also in AU·FR·SG
150 mg/1 mLinjectionTakhzyro 300mg/2ml solution for injection pre-filled syringes also in FR

CA 4 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

150 mgliquidTAKHZYRO also in US
150 mg/1 mLliquidTAKHZYRO

US 3 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

150 mgliquidTAKHZYRO also in CA
300 mg/2 mLliquidTAKHZYRO
300 mg/2.25 mLinjectionManufacturer: Catalent Indiana, LLC

FR 3 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

300 mg/2 mLinjectionTAKHZYRO 150 mg, solution injectable en seringue préremplie+1TAKHZYRO 300 mg, solution injectable also in AU·GB·SG
150 mg/1 mLinjectionTAKHZYRO 150 mg, solution injectable en seringue préremplie also in GB

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

300 mg/2 mLinjectionTAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML also in AU·GB·FR
150 mg/mLinjectionTAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

300 mginjectionTAKHZYRO PRECARGADA also in AU
150 mginjectionTAKHZYRO PRECARGADA also in AU

TW 1 records · 0 shown of 0 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Takhzyro solution for injection ×1得釋腫注射劑 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名TAKHZYRO ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	HK	EU	FR
300 mg/2 mL injection	not recorded	Takhzyro 300mg/2ml solution for injection pre-filled pens Takhzyro 300mg/2ml solution for injection pre-filled syringes Takhzyro 300mg/2ml solution for injection vials	not recorded	TAKHZYRO	TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML	not recorded	not recorded	not recorded	not recorded	TAKHZYRO 150 mg, solution injectable en seringue préremplie TAKHZYRO 300 mg, solution injectable
300 mg injection	not recorded	not recorded	not recorded	TAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe TAKHZYRO lanadelumab 300mg/2mL solution for injection vial	not recorded	TAKHZYRO PRECARGADA	not recorded	not recorded	not recorded	not recorded
150 mg liquid	TAKHZYRO	not recorded	TAKHZYRO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/1 mL injection	not recorded	Takhzyro 300mg/2ml solution for injection pre-filled syringes	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	TAKHZYRO 150 mg, solution injectable en seringue préremplie
150 mg injection	not recorded	not recorded	not recorded	TAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe	not recorded	TAKHZYRO PRECARGADA	not recorded	not recorded	not recorded	not recorded
300 mg/2 mL liquid	TAKHZYRO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/1 mL liquid	not recorded	not recorded	TAKHZYRO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg/2.25 mL injection	Manufacturer: Catalent Indiana, LLC	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/mL injection	not recorded	not recorded	not recorded	not recorded	TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Takhzyro PFS	not recorded	not recorded	not recorded	TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML	TAKHZYRO	not recorded
not disclosed injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Takhzyro solution for 得釋腫注射劑	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in CA · SG · TW and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · SG · TW que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · SG · TW 有记录（未在本表显示）。另有 3 個規格/劑型僅在 CA · SG · TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.